HAMP and prostate carcinoma: Previous studies have already revealed the adverse effect of hepcidin in prostate cancer (Tesfay et al., 2015; Wang et al., 2017; Zhao et al., 2018); however, no similar analysis of hepcidin expression in male genitourinary system tumors has been published.